ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19
Clinical trial NCT04583969 · COMPLETED
Trial details
- NCT number
- NCT04583969
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-23
- Primary completion
- 2022-04-22
- Enrollment
- 527
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.